(Jun. 13, 2023) — While U.S. health agencies have admitted that myocarditis (heart inflammation), and a related condition called pericarditis (inflammation of the heart sac), are potential side effects of the COVID jab,1 the U.S. Centers for Disease Control and Prevention has ignored hundreds of other safety signals that have shown up during their Proportional Reporting Ratio (PRR) data mining of the Vaccine Adverse Event Reporting System (VAERS).
For example, in individuals aged 18 and older, there are 770 safety signals for different adverse events, and more than 500 of them have a stronger safety signal than myocarditis and pericarditis.2
Range of Eye Problems Reported Post-Jab
The broad range of reported side effects is also astounding. They involve just about every part, organ and system of the body, including a range of eye problems. For example, looking at the list of reported side effects in 18-and-over age group in the CDC’s PRR document,3 we find:
| Ocular discomfort |
| Eye contusions (bruising) |
| Eye color change |
| Eyelid sensory disorder |
| Hypoesthesia eye (numbness of the eye, typically resulting from nerve damage and/or blood clots that result in tissue damage) |
| Retinal vein occlusion (blood clot in the vein that carries deoxygenated blood from your retina back to your heart) |
| Retinal artery occlusion (blood clot in the artery that feeds blood to your retina) |
| Eye hemorrhage |
| Retinal migraine (a retinal disease accompanied by migraine caused by ischemia or vascular spasm in or behind the affected eye; bouts can cause diminished vision or temporary blindness) |
| Ophthalmic migraine (a nervous system problem typically involving the third, fourth or sixth cranial nerves that allow for various eye movements; the condition is associated with severe headache and pain around the eyes; double vision is common during bouts) |
Ophthalmic Vascular Events Linked to COVID Jab
Two recent papers specifically highlight the risk of ophthalmic vascular events, which can lead to blindness, following the COVID jab. Basically, what we’re talking about are acute ischemic strokes that affect the eyes and can cause permanent loss of vision.
For example, according to research4 published in 2021, less than 20% of patients who experience central retinal artery occlusion,5 i.e., a blockage in the main artery of the retina, regain functional visual acuity in the affected eye.
The first paper, a systematic review6 of 49 studies published in the journal Vaccines in December 2022, found that most vascular events involving the eyes (46.2%) occurred after the first dose, and were more common after the Pfizer and AstraZeneca shots.
“Ophthalmic vascular events are serious vision-threatening side effects that have been associated with COVID-19 vaccination. Clinicians should be aware of the possible association between COVID-19 vaccines and ocular vascular events to provide early diagnosis and treatment,” the authors concluded.
Download this Article Before it Disappears
Prolonged Increased Risk of Blindness Post-Jab
The second article was published May 2, 2023 in NPJ Vaccines.7 Here, the researchers did a risk assessment to determine just how common retinal vascular occlusion — which can cause blindness — was after the COVID-19 jab. The results were devastating.
Across age groups, the risk more than doubled in the two years following the shot. For a detailed breakdown of retinal vascular occlusion incidence among various age groups, genders and ethnicities, see Table 2 on this page.8 According to Retsef Levi, that amounts to one additional case for every 300 seniors jabbed (age 64 and older), and one additional case for every 1,000 people jabbed between the ages of 18 and 64.9
According to the CDC,10 58,739,476 seniors aged 65 and older have received at least one dose. Divide that by 300, and we could be looking at 195,798 additional cases of retinal vascular occlusion and potential blindness among the elderly. And that’s just in the United States.
If we look at the 18 and older age group, the CDC claims 238,163,284 Americans have received at least one dose.11 Divide that by 1,000, and we’re potentially looking at an additional 238,163 instances of eye damage that could lead to blindness.
That’s an awful lot of visually impaired people. For reference, in 2017, an estimated 1.08 million Americans were blind.12 Of that 1.08 million, only 141,000 were younger than 40 (about 13%).
Read the rest here for a limited time.